
Results 1 - 17 of 17 in Discovery Partners International
Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins, president and chief business officer, was named the 2009 "Best Executive: Non-Services Business" in the 6th Annual Stevie Awards for Women in Business, presented at the Annual Award Dinner and Ceremony held on ... Comment?
Infinity Pharma 3Q loss narrows on payments
Infinity Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on a boost in payments from its partnership with Purdue Pharmaceutical Products LP and Mundipharma International Corp. Comment?
Infinity to Present at Upcoming Conferences
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that management will present a company overview at two upcoming conferences. Comment?
Aileron Therapeutics appoints Kafka as CFO
Protein-focused biotech company Aileron Therapeutics Inc. has named Steven Kafka as its chief financial officer and vice president of finance and operations. Comment?
Aileron Therapeutics Appoints Steven Kafka, Ph.D. as Company's First...
Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called Stapled Peptides, announced today that it has appointed Steven Kafka, Ph.D., as the Company's first Chief Financial Officer and Vice President, Finance and Operations. Comment?
Managing capacity planning with thin provisioning
While thin provisioning is used at many sites for utilization improvements , it has another important role. Comment?
Griffin Securities Announces Investment Opinion on Targeting Cancer Stem Cells
Griffin Securities , a research-driven investment banking firm, has released an industry report on the subject of targeting cancer stem cells . Comment?
Human Capital: People on the move, Oct. 8
Infinity Pharmaceuticals Inc. of Cambridge appointed Dr. Thomas Lynch a director and to the research and development committee of the board. Comment?
Thomas Lynch takes board seat at Infinity Pharmaceuticals
... was founded in 2001. In September 2006, the company completed its acquisition of Discovery Partners International Inc., a publicly traded company based in San Diego. Following that deal, reportedly worth about $100 million, Infinity became publicly ... Comment?
Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr., M.D., has been appointed to its Board of Directors. Comment?
Infinity to Present At Upcoming Conferences
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences. Comment?
Cancer Stem Cells Killed by Drug Compound, May Advance Push for Treatments
Scientists said they have found a drug compound that attacks in a new way the stem cells that fuel tumor growth, opening a path to a new type of anti-cancer treatment. Comment?
Drug compound that kills cancer stem cells identified
A drug that can selectively target and kill the stem cells that drive the growth of tumors has been identified for the first time by scientists who searched more than 16,000 compounds to find it. Comment?
Richard K. Brown, Ph.D. and John P. McDonough join CRia s Board of Directors
... with large pharmaceutical companies. Additionally, he held various executive positions at Discovery Partners International from 1995-2001, including President of IRORI where he participated in a successful IPO. Prior to DPI, Dr. Brown held various ... Comment?
News And FDA Updates For Theravance (NASDAQ:THRX), Auxilium...
News And FDA Updates For Theravance , Auxilium , Infinity Pharma , Momenta BioMedReports.com , the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA ... Comment?
Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, ...
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that the chemistry and data leading to the discovery of its novel Hedgehog signaling pathway inhibitor, IPI-926, have been published in the Journal of Medicinal Chemistry. Comment?
Infinity Pharmaceuticals Added to Russell 2000(r) Index
Infinity Pharmaceuticals, Inc. , an innovative cancer drug discovery and development company, today announced that it was added to the Russell 2000 Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 26, 2009. Comment?